Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA recalls more than 7,000 bottles of antidepressant
Thousands of bottles of popular antidepressant recalled: 3 things to know
Thousands of bottles of a popular antidepressant medication are being recalled due to the presence of what the National Library of Medicine describes as a toxic chemical, according to a notice from the U.
FDA recalls more than 7,000 bottles of antidepressant over a possible cancerous chemical
The FDA is recalling more than 7,000 bottles of the antidepressant duloxetine due to a possible cancer-causing chemical.
Urgent recall of popular antidepressant after cancer-causing compound detected
The FDA recently announced a recall of over 7,000 bottles of duloxetine after detecting elevated levels of N-nitroso-duloxetine, a potentially harmful compound that increases cancer risks
Common Antidepressant Recalled Over Cancer-Causing Chemical, FDA Warns
That's why it's so distressing to learn of a new drug recall issued by the U.S. Food and Drug Administration (FDA) in which 7,100 bottles of the antidepressant Duloxetine, distributed under the brand name Cymbalta,
Thousands of duloxetine bottles, an antidepressant sold as Cymbalta, recalled over toxic chemical
Some bottles of the antidepressant duloxetine, sold under the brand name Cymbalta, were recalled due to the presence of a toxic chemical.
7,100 bottles of antidepressant recalled by FDA now in 2nd highest risk class
Duloxetine Delayed-Release Capsules were recalled because the pills may contain high levels of a cancer-causing chemical.
FDA Has Recalled Thousands of Bottles of Antidepressant Duloxetine, Sold Under Brand Name Cymbalta: Here’s Why
The U.S. Food and Drug Administration has recalled thousands of bottles of the antidepressant Duloxetine (sold under the brand name Cymbalta) for potentially cancer-causing chemicals in the medication.
FDA issues recall for antidepressant drug
The Federal Drug Administration issued a recall on Tuesday for a common medicine for depression. Over 7,000 bottles of Duloxetine were recalled due to the elevated presence of Nitrosamine, an ingredient believed to be cancerous,
Antidepressant recalled: 2nd-highest FDA risk level; drug contains cancerous chemical
The U.S. Food and Drug Administration updated the risk level of a recalled antidepressant due to the product containing high levels of a cancer-causing chemical.
Antidepressant recall: FDA upgrades risk level due to cancer-causing chemical
Now, the FDA is assigning the second-highest risk level to the recall of Duloxetine Delayed-Release Capsules, produced by Towa Pharmaceutical Europe, according to agency records and reported by SILive.com sister site NJ.com. Duloxetine is used to treat depression, anxiety and nerve pain caused by fibromyalgia.
FDA Recalls Thousands of Bottles of Antidepressant Duloxetine: Here's Why
In a shocking turn of events, over 7,100 bottles of the antidepressant Duloxetine were recalled due to a potential cancer risk.
7h
This antidepressant is being recalled: Here’s why
The U.S. Food and Drug Administration (FDA) has issued a nationwide recall of thousands of bottles of antidepressants. These ...
1d
Antidepressant recall: FDA upgrades medication risk class to 2nd highest level in recall update
The U.S. Food and Drug Administration is urging patients not to stop taking their prescribed medication if it falls under the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
NK troops in RU confirmed
Linked to E. coli outbreak
Arlington visit records order
Trespassing charge upheld
Veteran film producer dies
2 US troops injured in raid
MO court upholds release
Dodgers legend dies
To close 150 locations
Lake Erie toxic algae study
Gun assault trial delayed
US fines American Airlines
Giant ‘ghost’ fish spotted
DOJ alleges racial bias
First father-son duo in NBA
Funds corruption guilty plea
FDA approves RSV vaccine
Bird flu infects 4 in WA
GA election rules appeal
G7 Ukraine loan advances
To appear on Rogan podcast
FAA finalizes safety rules
Brain stimulation study
US semiconductor tax credit
Six indicted for fraud in Ohio
Hospitals' IV fluid shortage
Related topics
Cymbalta
Duloxetine
Food and Drug Administration
Feedback